메뉴 건너뛰기




Volumn 51, Issue 10, 2003, Pages 1510-1511

Cholesterol and osteoporosis in postmenopausal women: A pilot study [7]

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 0141889071     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2003.514847.x     Document Type: Letter
Times cited : (2)

References (10)
  • 1
    • 0034838788 scopus 로고    scopus 로고
    • Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in post menopausal women
    • Yamauchi M, Sugimoto T, Yamaguchi T et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in post menopausal women. Clin Endocrinol (Oxford) 2001;55:341-347.
    • (2001) Clin Endocrinol (Oxford) , vol.55 , pp. 341-347
    • Yamauchi, M.1    Sugimoto, T.2    Yamaguchi, T.3
  • 2
    • 0036252175 scopus 로고    scopus 로고
    • Plasma lipids and osteoporosis in post menopausal women
    • Yamaguchi T, Sugimoto T, Yano S et al. Plasma lipids and osteoporosis in post menopausal women. Endocr J 2002;49:211-217.
    • (2002) Endocr J , vol.49 , pp. 211-217
    • Yamaguchi, T.1    Sugimoto, T.2    Yano, S.3
  • 3
    • 0033521078 scopus 로고    scopus 로고
    • Stimulation of bone formation in vitro and in rodents by statins
    • Mundy G, Garrett R, Harris S et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-1949.
    • (1999) Science , vol.286 , pp. 1946-1949
    • Mundy, G.1    Garrett, R.2    Harris, S.3
  • 4
    • 0034725357 scopus 로고    scopus 로고
    • HMG-CoA reductase inbibitors and the risk of hip fractures in elderly patients
    • Wang PS, Solomon DH, Mogun H et al. HMG-CoA reductase inbibitors and the risk of hip fractures in elderly patients. JAMA 2000;283:3211-3216.
    • (2000) JAMA , vol.283 , pp. 3211-3216
    • Wang, P.S.1    Solomon, D.H.2    Mogun, H.3
  • 5
    • 18544410718 scopus 로고    scopus 로고
    • Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
    • Chan KA, Andrade SE, Boles M et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 2000;355:2185-2188.
    • (2000) Lancet , vol.355 , pp. 2185-2188
    • Chan, K.A.1    Andrade, S.E.2    Boles, M.3
  • 6
    • 0034957690 scopus 로고    scopus 로고
    • The effect of fluvastatin on parameters of bone remodeling
    • Bjarnason NH, Riis BJ, Christiansen C. The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int 2001;12:380-384.
    • (2001) Osteoporos Int , vol.12 , pp. 380-384
    • Bjarnason, N.H.1    Riis, B.J.2    Christiansen, C.3
  • 7
    • 0034454445 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
    • Chung YS, Lee MD, Lee SK et al. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 2000;85:1137-1142.
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 1137-1142
    • Chung, Y.S.1    Lee, M.D.2    Lee, S.K.3
  • 8
    • 0035901052 scopus 로고    scopus 로고
    • Effect of pravastatin on frequency of fracture in the Lipid study: Secondary analysis of a randomized controlled trial
    • Reid IR, Hague W, Emberson J et al. Effect of pravastatin on frequency of fracture in the Lipid study: Secondary analysis of a randomized controlled trial. Lancet 2001;357:509-512.
    • (2001) Lancet , vol.357 , pp. 509-512
    • Reid, I.R.1    Hague, W.2    Emberson, J.3
  • 9
    • 0033958778 scopus 로고    scopus 로고
    • Alendronate is a specific nana molar inhibitor of farnesyl diphosphate synthase
    • Bergstrom JD, Bostedor RG, Masarachia PJ et al. Alendronate is a specific nana molar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 2000;373:231-241.
    • (2000) Arch Biochem Biophys , vol.373 , pp. 231-241
    • Bergstrom, J.D.1    Bostedor, R.G.2    Masarachia, P.J.3
  • 10
    • 0036190491 scopus 로고    scopus 로고
    • Statin use, bone mineral density, and fracture risk: Geelong osteoporosis study
    • Pasco JA, Kotowicz MA, Henry MJ et al. Statin use, bone mineral density, and fracture risk: Geelong osteoporosis study. Arch Intern Med 2002;162:537-540.
    • (2002) Arch Intern Med , vol.162 , pp. 537-540
    • Pasco, J.A.1    Kotowicz, M.A.2    Henry, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.